{"id":"NCT02395653","sponsor":"The Medicines Company","briefTitle":"Safety and Clinical Utility Study of SSEC Fentanyl 40 mcg for Acute Post-op Pain Management in Pediatric Participants","officialTitle":"An Open Label Evaluation of the Safety and Clinical Utility of the Active, Separated System With Enhanced Controller (SSEC) Fentanyl 40 mcg for the Management of Acute Postoperative Pain in Pediatric Patients 12 to Less Than 18 Years of Age","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2015-06-29","primaryCompletion":"2016-09-12","completion":"2016-09-12","firstPosted":"2015-03-23","resultsPosted":"2017-09-18","lastUpdate":"2017-10-26"},"enrollment":71,"design":{"allocation":"NA","model":"SINGLE_GROUP","masking":"NONE","primaryPurpose":"SUPPORTIVE_CARE"},"conditions":["Pain, Postoperative"],"interventions":[{"type":"DRUG","name":"fentanyl","otherNames":["IONSYS"]}],"arms":[{"label":"SSEC Fentanyl","type":"EXPERIMENTAL"}],"summary":"The objective of this study is to evaluate the safety and clinical utility of the active, SSEC fentanyl 40 micrograms (mcg) for the management of acute, postoperative pain in pediatric participants.","primaryOutcome":{"measure":"Assessment Of Participant's Ability To Use The SSEC","timeFrame":"Completed at the time of the participant's termination of study treatment (up to 72 hours after study drug administration)","effectByArm":[{"arm":"SSEC Fentanyl","deltaMin":1,"sd":null}],"pValues":[]},"eligibility":{"minAge":"12 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":9,"exclusionCount":10},"locations":{"siteCount":10,"countries":["United States"]},"refs":{"pmids":["14742382","17519263","17138198","18028044","20642249","15026400","16368828","17959978"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":1,"n":61},"commonTop":["Vomiting","Nausea","Constipation","Application site erythema","Application site papules"]}}